NovoCure Limited (NVCR)

NovoCure Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2022	FY 2019	FY 2014
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2022	Dec 31, 2019	Dec 31, 2014
Cash & Equivalents	93.55	163.77	115.33	177.32	57.61
Short-Term Investments	354.13	796.11	854.1	148.77	45
Cash & Short-Term Investments	447.67	959.87	969.43	326.09	102.61
Cash Growth	-53.36%	-0.98%	197.29%	217.79%	-41.66%
Accounts Receivable	89.44	74.23	86.26	58.86	-
Inventory	41.11	35.09	29.38	23.7	3.45
Other Current Assets	68.51	37.39	26.47	31.3	5.77
Total Current Assets	646.73	1,107	1,112	439.95	111.83
Net Property, Plant & Equipment	147	119.59	68.96	34.6	5.75
Other Long-Term Assets	10.6	14.62	11.16	4.9	0.3
Total Assets	804.33	1,241	1,192	479.45	117.88
Accounts Payable	122.23	105.09	85.2	36.93	10.03
Accrued Expenses	101	93.15	73.58	49.39	7.64
Short-Term Debt	-	558.16	-	-	-
Total Current Liabilities	223.23	756.39	158.78	86.31	17.67
Long-Term Debt	195.05	97.3	565.51	149.42	-
Long-Term Leases	41.65	19.97	18.76	14.14	-
Other Long-Term Liabilities	3.94	6.94	7.43	11.78	2.33
Total Long-Term Liabilities	240.63	124.21	591.7	175.35	2.33
Total Liabilities	463.86	880.61	750.48	261.66	20
Additional Paid-in Capital	1,634	1,520	1,222	871.44	374.38
Accumulated Other Comprehensive Income	-3.44	-5.5	-2.43	-2.77	-
Retained Earnings	-1,290	-1,154	-778.46	-650.89	-276.5
Shareholders' Equity	340.47	360.18	441.17	217.79	97.88
Total Liabilities & Equity	804.33	1,241	1,192	479.45	117.88
Total Debt	236.69	675.43	584.27	163.56	0
Net Cash (Debt)	210.98	284.44	385.15	162.53	102.61
Net Cash Growth	-25.83%	-26.15%	136.98%	58.39%	-41.66%
Net Cash Per Share	1.89	2.64	3.66	1.62	-
Book Value	340.47	360.18	441.17	217.79	97.88
Book Value Per Share	3.05	3.34	4.19	2.17	-
Tangible Book Value	340.47	360.18	441.17	217.79	97.88
Tangible Book Value Per Share	3.05	3.34	4.19	2.17	-

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q